| Literature DB >> 26480852 |
Aaron T Garrison1, Yasmeen Abouelhassan1, Dimitris Kallifidas1, Fang Bai2, Maria Ukhanova3, Volker Mai3, Shouguang Jin2, Hendrik Luesch1, Robert W Huigens4.
Abstract
Conventional antibiotics are ineffective against non-replicating bacteria (for example, bacteria within biofilms). We report a series of halogenated phenazines (HP), inspired by marine antibiotic 1, that targets persistent bacteria. HP 14 demonstrated the most potent biofilm eradication activities to date against MRSA, MRSE, and VRE biofilms (MBEC = 0.2-12.5 μM), as well as the effective killing of MRSA persister cells in non-biofilm cultures. Frontline MRSA treatments, vancomycin and daptomycin, were unable to eradicate MRSA biofilms or non-biofilm persisters alongside 14. HP 13 displayed potent antibacterial activity against slow-growing M. tuberculosis (MIC = 3.13 μM), the leading cause of death by bacterial infection around the world. HP analogues effectively target persistent bacteria through a mechanism that is non-toxic to mammalian cells and could have a significant impact on treatments for chronic bacterial infections.Entities:
Keywords: bacterial biofilms; biofilm eradication; halogenated phenazines; marine antibiotics; medicinal chemistry
Mesh:
Substances:
Year: 2015 PMID: 26480852 DOI: 10.1002/anie.201508155
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336